DEFERASIROX
deferasirox 180 mg tablet, 30
DEFERASIROX (11535D)
11535D
Body System:
Manner of administration:Oral
Restriction 8328
Indication: Chronic iron overload
Treatment phase: Continuing treatment
Restriction 8329
Indication: Chronic iron overload
Treatment phase: Continuing treatment
Restriction 8326
Indication: Chronic iron overload
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 6 | Max qty units: 180 | # of repeats: 2 | DPMQ: $174.12 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||